Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Other Non-Current Liabilities (2016 - 2026)

Metlife's Other Non-Current Liabilities history spans 18 years, with the latest figure at $58.0 billion for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 49.29% to $58.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $58.0 billion through Mar 2026, up 49.29% year-over-year, with the annual reading at $57.6 billion for FY2025, 56.29% up from the prior year.
  • Other Non-Current Liabilities came in at $58.0 billion for Q1 2026, up from $57.6 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $58.0 billion in Q1 2026 to a low of $23.9 billion in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $36.2 billion (2024), against an average of $36.7 billion.
  • Year-over-year, Other Non-Current Liabilities fell 2.33% in 2022 and then soared 56.29% in 2025.
  • Metlife's Other Non-Current Liabilities stood at $25.9 billion in 2022, then soared by 38.07% to $35.8 billion in 2023, then grew by 2.9% to $36.8 billion in 2024, then soared by 56.29% to $57.6 billion in 2025, then increased by 0.71% to $58.0 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Other Non-Current Liabilities are $58.0 billion (Q1 2026), $57.6 billion (Q4 2025), and $48.5 billion (Q3 2025).